The battle for Paxlovid →

in

Rich countries are snapping up available Covid-19 treatments, leaving the rest of the world months away from gaining access. The wait in some middle-income countries could be even longer.

“We still have deaths every day, and coming into winter it will increase,” said Luis Villarroel Villalón, who leads a nonprofit in Chile that provides legal services. His is among the dozens of middle-income countries looking at a wait, which could stretch well into 2023, for the new treatments, particularly Pfizer’s oral antiviral, Paxlovid. “Lives could be saved through Paxlovid,” said Villalón. Read more.